Serotonin-Producing Bacteria Screening Through Aerobic Tryptophan Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for serotonin deficiency, such as SSRIs and MAO inhibitors, are associated with severe side effects and are not suitable for all patients, highlighting a need for safe and effective alternatives to increase serotonin levels.
Innovation Solution
Screening and selecting lactic acid producing bacterial strains capable of producing serotonin under aerobic conditions, particularly in the gastrointestinal tract, to treat serotonin deficiency and related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional drugs (SSRIs, MAO inhibitors) are used to treat serotonin deficiency, then serotonin levels increase, but severe side effects occur
Solution Approach 1:
The patent introduces gut microbiota as an intermediary substance that produces serotonin naturally. Instead of using conventional drugs directly, the bacteria act as mediators to synthesize serotonin in the gut, which then affects the host without the harmful side effects of pharmaceutical interventions. This is supported by the background describing how gut microbiota metabolites regulate host serotonin production and the invention claiming bacteria that produce serotonin without the side effects of conventional treatments.
Solution Approach 2:
The patent employs the host's own gut microbiota to self-produce serotonin, eliminating the need for external drug intervention. The bacteria utilize the host's tryptophan substrate to synthesize serotonin autonomously, creating a self-sustaining system that regulates serotonin levels without requiring pharmaceutical agents. This is evident in the background discussing endogenous serotonin production regulation by gut microbiota and the invention's focus on bacteria that can produce serotonin using host resources.
2Quantity of substance
If conventional drugs are used to increase serotonin, then serotonin deficiency is treated, but the drugs are not suitable for all patients due to contraindications
Solution Approach 1:
The patent enables the host's gut microbiota to self-regulate serotonin production based on individual needs, eliminating the need for standardized pharmaceutical prescriptions. Each patient's unique microbiota composition can naturally adapt to produce appropriate serotonin levels, making the treatment universally applicable without the contraindications that limit drug suitability. This is supported by the background on individual variations in serotonin production and the invention's emphasis on personalized microbiota-based treatment.
Solution Approach 2:
The patent utilizes changes in microbial community composition and metabolic activity to adjust serotonin production levels dynamically. By modulating factors such as diet, probiotic introduction, or prebiotic supplementation, the system can adapt serotonin synthesis to individual patient requirements without the rigid dosing constraints of conventional drugs. This is evident in the background discussing regulation of TPH1 expression and the invention's focus on modulating bacterial serotonin production capacity.
3Quantity of substance
If lactic acid producing bacteria are screened for serotonin production, then effective strains are identified, but the screening process is complex
Solution Approach 1:
The patent extracts and isolates specific functional genes (such as those encoding tryptophan hydroxylase or aromatic L-amino acid decarboxylase) from the bacterial genome to create simplified screening markers. Instead of analyzing entire bacterial communities, the method focuses on detecting these specific genetic elements, significantly reducing the complexity of serotonin production screening while maintaining accuracy. This is supported by the background on serotonin synthesis enzymes and the invention's likely use of molecular biology techniques to detect bacterial serotonin synthesis capability.
Solution Approach 2:
The patent uses intermediate substances such as tryptophan metabolites or bacterial cell surface markers as proxies for direct serotonin measurement. These intermediaries serve as easier-to-detect indicators that correlate with serotonin production capability, simplifying the screening process without requiring direct detection of the neurotransmitter itself. This approach is consistent with the background on metabolic signaling and the invention's focus on identifying bacteria with serotonin synthesis potential through accessible markers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The identified bacterial strains effectively increase serotonin levels locally and systemically, improving enteric nervous system maturation and providing therapeutic benefits without significant side effects.
Implementation Method 1
Serotonin production is enabled by the rate limiting enzyme tryptophan hydroxylase (TPH), which produces 5-hydroxytryptophan (5-HTP).
Implementation Method 2
5-HTP is the immediate precursor of serotonin and is converted into serotonin by the aromatic L-amino-acid decarboxylase (AADC).
Implementation Method 3
Lactobacilli and other lactic acid producing bacteria... produce specific substances, such as hydrogen peroxide, bacteriocins and/or organic acids, including lactic and acetic acid
Data Source
AI summary
The invention relates to selection of bacterial strain for use in treating serotonin deficiency and/or a disease related to serotonin deficiency by culturing bacteria of a lactic acid producing bacterial strain, under aerobic conditions, in a culture medium comprising tryptophan. Any serotonin produced by the bacteria of the lactic acid producing bacterial strain in the culture medium is detected and the lactic acid producing bacterial strain is selected as effective in treating serotonin deficiency and/or a disease related to serotonin deficiency in a subject if serotonin is detected in the culture medium.